| The New Business Development |
|
| Developing new medicines and vaccines is an expensive and risky business. In order to ensure a strong pipeline of new products, we have close associations with collaborators having qualified scientists with postdoctoral experience in drug discovery, drug delivery systems, process development and analytical research. Specialty products with new formulas and latest drugs developed with all underlying studies, unique features and market surveys are synergised with our |
| working strategies by way of in-licensing, co-marketing and co-promoting new products with other businesses. We obtain product approvals, take Pilot batches and then proceed with commercial batches that then marketed and distributed. This helps to ensure that our business grows and compliments the existing products with new ones that offer new or more effective treatments for disease. |
 |
|
